A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab. - Wikidata - wikimedia - TriplyDB

A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.

A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.

http://www.wikidata.org/entity/Q33420998

about

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome Liver transplantation for aHUS: still needed in the eculizumab era?Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern.Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.

P2860

Q26750692-943192B4-B634-4809-B20E-E58542074949 Q33427846-2A76DC14-48F1-4C43-B192-CB2205684715 Q33436307-6C147D3B-45B1-4E92-B7E8-7F896D6C6957 Q33439434-47710804-5C1D-4EBB-A407-37367EAF6BA5 Q33783126-3CDD3CDD-02BC-4337-A996-C6EACB3ADD1A Q37497101-4F4D5632-767E-4838-9B5F-9BF0A947FFE1 Q47102552-566B4A25-8415-4526-BF47-899B89591E32 Q48114152-C15C0883-DE52-46FD-8758-B238D9E6CDF5 Q48241051-C0B54C94-4662-4FA4-A7B1-6157026EA0AC

P2860

A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.

http://www.wikidata.org/entity/Q33420998

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

A complicated case of atypical ...... ent relapses under eculizumab.

@ast

A complicated case of atypical ...... ent relapses under eculizumab.

@en

type

label

A complicated case of atypical ...... ent relapses under eculizumab.

@ast

A complicated case of atypical ...... ent relapses under eculizumab.

@en

prefLabel

A complicated case of atypical ...... ent relapses under eculizumab.

@ast

A complicated case of atypical ...... ent relapses under eculizumab.

@en

P1433

Q33420998-D96AF259-CF03-4283-8343-912670ADDA07

P1476

Q33420998-12076C3F-77E3-4771-B1B1-1BF2AD9C9704

P2093

Q33420998-25C90C07-3AB5-4AD9-8FA1-9CF8C6547672

Q33420998-2AB769A1-AA8C-4B46-B981-755824AEA5C2

Q33420998-34FA2EA6-81C2-4001-B849-A61F14AA83EB

Q33420998-9D713011-6D97-40E8-9479-BAED53F72B71

Q33420998-A8C1D9AB-6E55-4721-80B0-3571C8C8F7AB

Q33420998-AA2DE8A4-0965-4F10-B7DB-C9D14E99B39A

Q33420998-C93B5A82-D06A-4B0D-9767-60E69DEA708A

P2860

Q33420998-0142EC74-0CF2-4E5B-9E14-15768C1A8413

Q33420998-14444D40-D896-4FF2-BC17-E65BC0782472

Q33420998-2C3A1D0E-E548-480F-B29D-6F9F6547E7F2

Q33420998-2D950D86-B829-46AF-9879-3C525E940AFD

Q33420998-3DCF6ADA-8FC4-478B-8050-30293C9CC7F0

Q33420998-4905D3F8-C315-4CFC-9C4E-AF8FF01F6156

Q33420998-5B63D132-C6F0-42B8-B30B-B9EC43B4C5A5

Q33420998-5E52FFDF-6503-450D-A835-E099B561E2DB

Q33420998-75B0BB4F-D53E-46E6-BA20-30A0A585CF66

Q33420998-77E78F53-5BE2-4DFB-A760-A539C460251C

P2888

Q33420998-9C73F1AB-2039-43EC-84F9-8AE2F013457B

P304

Q33420998-DE341270-5DDB-4EE2-8B23-179D267D5F40

P31

Q33420998-39A78D77-4389-4244-8E3C-33F3A6B1B486

P356

Q33420998-038E7EC5-7896-4A37-9422-C56230B43C76

P433

Q33420998-74016FFE-D76F-4A4C-A6B8-6D62DC9A3304

P478

Q33420998-66B062BA-6A5D-4156-913F-ECFDF642F42D

P577

Q33420998-0E7FD92E-EE08-4CE4-836A-D04FCDB3E73D

P6179

Q33420998-A698A639-6CF4-4C32-98EC-FB5D51B8CEC2

P698

Q33420998-2D6391D3-7AB1-40B1-9EF9-19D69322C8DA

P356

S00467-015-3078-6

P1433

Pediatric Nephrology

P1476

A complicated case of atypical ...... ent relapses under eculizumab.

@en

P2093

Bernd Hoppe

http://www.w3.org/2001/XMLSchema#string

Carsten Bergmann

http://www.w3.org/2001/XMLSchema#string

Cyrill Wehling

http://www.w3.org/2001/XMLSchema#string

Gesa Schalk

http://www.w3.org/2001/XMLSchema#string

Lutz T Weber

http://www.w3.org/2001/XMLSchema#string

Michael Kirschfink

http://www.w3.org/2001/XMLSchema#string

Sara Gastoldi

http://www.w3.org/2001/XMLSchema#string

P2860

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

Genetics and complement in atypical HUS.

Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.

STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

P2888

s00467-015-3078-6

P304

1039-1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-015-3078-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048122339

http://www.w3.org/2001/XMLSchema#string

P698

25752761

http://www.w3.org/2001/XMLSchema#string